Government advisors have recommended that prostate cancer screening should be offered only to a few thousand men with a dangerous genetic variant and a family history of cancer, rejecting calls for a wider national programme.
Prostate cancer is the most common cancer in the UK, but unlike breast, bowel and lung cancer, there is currently no national screening programme. The decision by UK advisors means that only men at the highest genetic risk will be eligible for screening, leaving the majority of men without routine checks.
“UK advisors recommend prostate cancer screening only for men with a dangerous genetic variant and family history, rejecting calls for a national programme. Thousands of men could face avoidable deaths.”
The advice applies across England, Scotland, Wales and Northern Ireland. Critics argue that thousands of men could face avoidable deaths without a broader screening programme, as early detection is key to successful treatment.
The UK advisors stated that screening should be limited to those with a dangerous genetic variant and a family history of cancer. No direct quotes were provided, but the recommendation reflects a cautious approach to avoid overdiagnosis and unnecessary treatment.
The government is expected to consider the advice, though no timeline for implementation has been given. Campaigners are likely to continue pushing for a full national screening programme, similar to those for other cancers.
What This Means For You: Men with a family history of prostate cancer or known genetic variants may be eligible for screening. For most men, routine screening will not be offered, so awareness of symptoms – such as difficulty urinating or blood in urine – remains crucial. The decision may lead to delays in diagnosis for some, highlighting the importance of discussing concerns with a GP.